MUSTANG BIO INC

For the period ended Jun 30, 2024. Filed Aug 13, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 13, 2024

MBIO$0.39-0.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 6. Exhibits

The exhibits listed on the Exhibit Index are either filed or furnished with this report or incorporated herein by reference.

EXHIBIT INDEX

Exhibit No.		Description

4.1		Form of Pre-Funded Warrant (May 2024) (incorporated by reference to Exhibit 4.1 to the Registrant’s Current Report on Form 8-K filed on May 2, 2024 (File No. 001-38191)).

4.2		Form of Series A-1, A-2, and A-3 Warrant (May 2024) (incorporated by reference to Exhibit 4.2 to the Registrant’s Current Report on Form 8-K filed on May 2, 2024 (File No. 001-38191)).

4.3		Form of Placement Agent Warrant (May 2024) (incorporated by reference to Exhibit 4.3 to the Registrant’s Current Report on Form 8-K filed on May 2, 2024 (File No. 001-38191)).

4.4		Form of Pre-funded Warrant (June 2024) (incorporated by reference to Exhibit 4.1 to the Registrant’s Current Report on Form 8-K filed on June 21, 2024 (File No. 001-38191)).

4.5		Form of Warrant (June 2024) (incorporated by reference to Exhibit 4.2 to the Registrant’s Current Report on Form 8-K filed on June 21, 2024 (File No. 001-38191)).

4.6		Form of Wainwright Warrant (June 2024) (incorporated by reference to Exhibit 4.3 to the Registrant’s Current Report on Form 8-K filed on June 21, 2024 (File No. 001-38191)).

10.1		Form of Securities Purchase Agreement, dated April 29, 2024, by and between the Company and the purchaser party thereto (incorporated by reference to Exhibit 10.1 of the Registrant’s Current Report on Form 8-K filed on May 2, 2024 (File No. 001-38191)).

10.2		Warrant Amendment Agreement, dated April 29, 2024, by and between the Company and purchaser party thereto (incorporated by reference to Exhibit 10.2 of the Registrant’s Current Report on Form 8-K filed on May 2, 2024 (File No. 001-38191)).

10.3		Form of Securities Purchase Agreement, dated June 19, 2024, by and between the Company and the purchaser party thereto (incorporated by reference to Exhibit 10.1 of the Registrant’s Current Report on Form 8-K filed on June 21, 2024 (File No. 001-38191)).

31.1		Certification of President and Chief Executive Officer (Principal Executive Officer), pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).

31.2		Certification of Interim Chief Financial Officer (Principal Financial Officer), pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).

32.1		Certification of President and Chief Executive Officer (Principal Executive Officer), pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).

32.2		Certification of Interim Chief Financial Officer (Principal Financial Officer), pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).

101		The following financial information from the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2024, formatted as Inline Extensible Business Reporting Language (iXBRL): (i) the Balance Sheets, (ii) the Unaudited Statements of Operations, (iii) the Unaudited Statement of Stockholders’ Equity, (iv) the Unaudited Statements of Cash Flows, and (v) Notes to the Unaudited Financial Statements (filed herewith).

104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in exhibit 101)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.